IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Industrial Biotech

Pfizer Opens Biotech Plant in Sweden

4:00 AM MDT | August 27, 2009 | Deepti Ramesh

Pfizer says it has opened a previously announced new facility for biotechnological pharmaceutical production at Strangnas, Sweden. Pfizer expects the plant, which was built with an investment of about €150 million ($213 million), to further strengthen its capacities in the rapidly growing biotech sector. The plant is Sweden’s largest site for the production of biotechnological pharmaceuticals, Pfizer says. “Biologics hold tremendous promise in changing the way patients are treated and diseases prevented,” says Rory O’Connor...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa